Found 9 matching trials
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
PHASE2This is a randomized trial to estimate the activity of R-ICE plus SGN-40 vs...
Location
University of Alabama at Birmingham
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
PHASE1This is a Phase I, open-label, multi-dose trial to define the MTD and toler...
Location
Rocky Mountain Cancer Center
Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma
PHASE2This is a Phase II, open-label, multidose trial of SGN-40 designed to estim...
Location
University of Alabama at Birmingham
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
PHASE1The purpose of this study is to determine the safety and activity of SGN-40...
Location
James R. Berenson M.D., Inc.
A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma
PHASE1This is an open-label, multi-dose, Phase I, dose escalation study to define...
Location
University of Alabama at Birmingham
Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL
PHASE1The purpose of this study is to determine safety and tolerability of combin...
Location
University of Alabama at Birmingham
A Safety Study in Patients With Chronic Lymphocytic Leukemia
PHASE1This is an open-label, dose-escalation study to determine the tolerability,...
Location
University of Alabama at Birmingham
A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1This is an open-label, multicenter, Phase Ib study to be conducted at appro...
Location
Multiple Locations
A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma
PHASE1This is an open-label, multicenter Phase Ib study designed to evaluate the ...
Location
Multiple Locations